Found: 4
Select item for more details and to access through your institution.
Circadian regulation of MGMT expression and promoter methylation underlies daily rhythms in TMZ sensitivity in glioblastoma.
- Published in:
- Journal of Neuro-Oncology, 2024, v. 166, n. 3, p. 419, doi. 10.1007/s11060-023-04535-9
- By:
- Publication type:
- Article
randomized feasibility study evaluating temozolomide circadian medicine in patients with glioma.
- Published in:
- Neuro-Oncology Practice, 2022, v. 9, n. 3, p. 193, doi. 10.1093/nop/npac003
- By:
- Publication type:
- Article
Correction to: Linkage, whole genome sequence, and biological data implicate variants in RAB10 in Alzheimer's disease resilience.
- Published in:
- 2018
- By:
- Publication type:
- Correction Notice
Linkage, whole genome sequence, and biological data implicate variants in RAB10 in Alzheimer’s disease resilience.
- Published in:
- Genome Medicine, 2017, v. 9, p. 1, doi. 10.1186/s13073-017-0486-1
- By:
- Publication type:
- Article